ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹262 Cr | ₹136 Cr | ₹144 Cr | ₹184 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹262 Cr |
| Mar2024 | ₹136 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹184 Cr |
| Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹262 Cr | 92.61 | |
| Mar2024 | ₹136 Cr | -5.55 | |
| Mar2023 | ₹144 Cr | -21.80 | |
| Mar2022 | ₹184 Cr | -2.87 | |
| Mar2021 | ₹190 Cr | - | |
Compare Total Non-Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹59,207.1 Cr | 3.8% | 8% | -8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 3.8% |
8% |
-8.2% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses